课题基金 / 基金详情

NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D

NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
艾滋病疫苗 R 非人灵长类核心定量 IR RNA 实验室
批准号：
8462168
负责人：
RANAJIT PAL
金额：
$93.15万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-03-30 至 2013-03-29
来源：
https://reporter.nih.gov/project-details/8462168
关键词：
AIDS VaccinesBiological AssayContractsDetectionHIVLaboratoriesLymphoid TissueMucous MembraneNational Institute of Allergy and Infectious DiseasePlasmaRNAReproducibilityResearch PersonnelSIVSiteSpecimenTechnologyUnited States National Institutes of Healthassay developmentdesignimprovednew technologynonhuman primateresearch and developmentsimian human immunodeficiency virusvaccine evaluationviral RNA

项目摘要

项目成果

RANAJIT PAL的其他基金

相似基金

相关文献

中文摘要
翻译
该合同将为NHP核心定量病毒RNA实验室提供支持，用于进行，改进和开发旨在检测和表征血浆，粘膜组织和分泌物，淋巴组织以及NHP感染SIV，SHIV，在NIAID猿猴疫苗评价单位（SVEU）合同地点或由NIH支持的研究者进行的研究中，
英文摘要
This contract will provide support for a NHP Core Quantitative Viral RNA Laboratory for the conduct, improvement, and development of assays designed to detect and characterize viral RNA in the plasma, mucosal tissues and secretions, lymphoid tissues, and other specimens from NHP that have been infected with SIV, SHIV, or HIV in studies conducted at the NIAID Simian Vaccine Evaluation Unit (SVEU) contract sites or by NIH-supported investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Statistical Support for HIV Non-vaccine Biomedical Prevention Product Development
EVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF HIV-1 CLADE C OLIGOMERIC ENVELOPE PROTEIN DELIVERED WITH ADVAX DELTA INULIN ADJUVANT BY INTRAMUSCULAR AND INTRAPULMONARY ROUTES
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
海外基金